Background: Transurethral balloon laser thermotherapy (TUBAL-T) improves objective, but not subjective, symptoms of benign prostatic hyperplasia (BPH). We studied whether or not an Nd:YAG laser beam with a shielded balloon could successfully irradiate the prostate during TUBAL-T in selective manner, to improve the subjective symptoms.
Methods: TUBAL-T was performed on canine prostates using the balloon with a laser probe, which was shielded anteriorly at 90 degrees (from the center of the balloon) and posteriorly at 90 degrees.
Results: At 20 watts laser power, the relative power density in the bilateral non-shielded areas was 17.4 and 17.8, and in the shielded area it was 1.0. Observation by thermography revealed that the temperature after laser radiation in a non-shielded area of a fish cake phantom was higher than in a shielded area. Following transurethral thermotherapy using a shielded balloon in dogs, a cavity was formed bilaterally around the urethra, and the tissues at the anteroposterior sides and the urethra were preserved.
Conclusions: TUBAL-T, which has been performed in clinical cases of benign prostatic hyperplasia, might be useful in selective irradiation of adenoma if a shielded balloon is used.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1442-2042.1996.tb00627.x | DOI Listing |
Obstet Gynecol
January 2025
Marian Regional Medical Center and CommonSpirit Health, Women and Infants Clinical Institute, Santa Maria, California; and the Dignity Health Medical Group, Phoenix, Arizona.
Circ Cardiovasc Interv
October 2024
Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor (D.E.H., D.S.K., M. Seth, H.S.G., D.S.).
Background: Coronary artery disease remains the largest contributor to cardiac arrests worldwide; yet, long-term outcomes are often driven by neurological status after resuscitation. We examined the association between pre-percutaneous coronary intervention (PCI) level of consciousness (LOC) and outcomes among patients with cardiac arrest who underwent PCI.
Methods: The study cohort included patients undergoing PCI after cardiac arrest between April 2018 and March 2022 at 48 hospitals in the state of Michigan.
AJNR Am J Neuroradiol
October 2024
From the Department of Radiology and Neuroradiology (L.G., D.Z., L.P., J.K., M.S., C.K.), University of Cologne, Faculty of Medicine and University Hospital, Cologne, Germany.
Background And Purpose: The Pipeline Embolization Device is a safe and effective treatment option for intracranial aneurysms. The newer Pipeline generations have received structural refinements and a surface modification to improve deliverability, procedural safety, and angiographic outcomes. This multicenter study evaluated the clinical safety and efficacy of the 2 surface-modified Pipeline iterations, Pipeline Vantage and Pipeline Flex with Shield Technology (PFS).
View Article and Find Full Text PDFCirc Cardiovasc Interv
February 2024
Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor (M.S., K.F., D.S., H.S.G.).
Background: Improved radiation safety practices are needed across hospitals performing percutaneous coronary intervention (PCI). This study was performed to assess the temporal trend in PCI radiation doses concurrent with the conduct of a statewide radiation safety initiative.
Methods: A statewide initiative to reduce PCI radiation doses was conducted in Michigan between 2017 and 2021 and included focused radiation safety education, reporting of institutional radiation doses, and implementation of radiation performance metrics for hospitals.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!